2024 Q2 Form 10-Q Financial Statement
#000142528724000101 Filed on May 20, 2024
Income Statement
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
Revenue | $842.4K | $1.339M |
YoY Change | -78.76% | -20.91% |
Cost Of Revenue | $7.301M | $7.443M |
YoY Change | -13.36% | 39.69% |
Gross Profit | -$6.459M | -$6.103M |
YoY Change | 44.79% | 67.92% |
Gross Profit Margin | -766.69% | -455.72% |
Selling, General & Admin | $12.07M | $14.10M |
YoY Change | -13.83% | -4.05% |
% of Gross Profit | ||
Research & Development | $1.993M | $3.528M |
YoY Change | -60.62% | -51.17% |
% of Gross Profit | ||
Depreciation & Amortization | $2.059M | $1.961M |
YoY Change | 175.87% | 206.21% |
% of Gross Profit | ||
Operating Expenses | $14.06M | $17.62M |
YoY Change | -26.25% | -19.58% |
Operating Profit | -$20.52M | -$23.73M |
YoY Change | -12.77% | -7.13% |
Interest Expense | -$5.159M | -$5.429M |
YoY Change | -1120.55% | -1086.47% |
% of Operating Profit | ||
Other Income/Expense, Net | ||
YoY Change | ||
Pretax Income | -$26.32M | -$29.16M |
YoY Change | 14.35% | 16.63% |
Income Tax | $0.00 | $0.00 |
% Of Pretax Income | ||
Net Earnings | -$26.32M | -$29.20M |
YoY Change | 14.35% | 16.8% |
Net Earnings / Revenue | -3124.26% | -2180.25% |
Basic Earnings Per Share | -$1.40 | -$0.10 |
Diluted Earnings Per Share | -$1.40 | -$0.10 |
COMMON SHARES | ||
Basic Shares Outstanding | 375.2M shares | 314.8M shares |
Diluted Shares Outstanding | 18.86M shares | 302.6M shares |
Balance Sheet
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $5.309M | $6.728M |
YoY Change | -91.49% | -91.49% |
Cash & Equivalents | $5.300M | $6.700M |
Short-Term Investments | ||
Other Short-Term Assets | $1.561M | $981.3K |
YoY Change | 88.67% | 36.51% |
Inventory | $46.50M | $49.85M |
Prepaid Expenses | ||
Receivables | $800.0K | $1.800M |
Other Receivables | $0.00 | $0.00 |
Total Short-Term Assets | $59.47M | $65.64M |
YoY Change | -52.15% | -50.59% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $36.50M | $38.54M |
YoY Change | 16.61% | 43.13% |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $176.3K | $176.3K |
YoY Change | 0.0% | 0.0% |
Total Long-Term Assets | $45.90M | $48.23M |
YoY Change | -12.79% | -0.63% |
TOTAL ASSETS | ||
Total Short-Term Assets | $59.47M | $65.64M |
Total Long-Term Assets | $45.90M | $48.23M |
Total Assets | $105.4M | $113.9M |
YoY Change | -40.44% | -37.22% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $10.50M | $14.20M |
YoY Change | 2.65% | -1.79% |
Accrued Expenses | $6.335M | $6.652M |
YoY Change | -85.28% | -85.23% |
Deferred Revenue | $6.955M | $4.690M |
YoY Change | 394.55% | 112.46% |
Short-Term Debt | $9.649M | $7.874M |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $41.69M | $41.40M |
YoY Change | -28.23% | -36.47% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $5.048M | $5.048M |
YoY Change | -55.9% | -55.74% |
Total Long-Term Liabilities | $5.048M | $5.048M |
YoY Change | -55.9% | -55.74% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $41.69M | $41.40M |
Total Long-Term Liabilities | $5.048M | $5.048M |
Total Liabilities | $46.74M | $46.45M |
YoY Change | -32.79% | -39.34% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$807.0M | -$780.7M |
YoY Change | 19.43% | 19.63% |
Common Stock | $20.74K | $330.8K |
YoY Change | -89.89% | 83.18% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $58.64M | $67.42M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $105.4M | $113.9M |
YoY Change | -40.44% | -37.22% |
Cashflow Statement
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$26.32M | -$29.20M |
YoY Change | 14.35% | 16.8% |
Depreciation, Depletion And Amortization | $2.059M | $1.961M |
YoY Change | 175.87% | 206.21% |
Cash From Operating Activities | -$12.10M | -$18.00M |
YoY Change | -63.39% | -44.95% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $733.6K | $3.026M |
YoY Change | -85.53% | -44.02% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | -$733.6K | -$3.026M |
YoY Change | -85.53% | -44.02% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 11.41M | -$8.128M |
YoY Change | -46.64% | -145.19% |
NET CHANGE | ||
Cash From Operating Activities | -12.10M | -$18.00M |
Cash From Investing Activities | -733.6K | -$3.026M |
Cash From Financing Activities | 11.41M | -$8.128M |
Net Change In Cash | -1.420M | -$29.12M |
YoY Change | -91.51% | 44.39% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$12.10M | -$18.00M |
Capital Expenditures | $733.6K | $3.026M |
Free Cash Flow | -$12.83M | -$21.03M |
YoY Change | -66.33% | -44.82% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
67423772 | usd |
CY2023Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3024389 | usd |
CY2024Q1 | us-gaap |
Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
|
9800000 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
10.27 | |
CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P6Y8M12D | |
CY2023 | us-gaap |
Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
|
http://fasb.org/us-gaap/2023#InterestIncomeExpenseNet | |
CY2022 | us-gaap |
Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
|
http://fasb.org/us-gaap/2023#InterestIncomeExpenseNet | |
CY2024Q1 | us-gaap |
Gross Profit
GrossProfit
|
-6103483 | usd |
CY2023Q1 | us-gaap |
Gross Profit
GrossProfit
|
-3634704 | usd |
CY2024Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
14095278 | usd |
CY2023Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
14689843 | usd |
CY2024Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3527911 | usd |
CY2023Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
7224849 | usd |
CY2024Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
17623189 | usd |
CY2023Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
21914692 | usd |
CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-23726672 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-25549396 | usd |
CY2024Q1 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
-5429115 | usd |
CY2023Q1 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
550359 | usd |
CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-29155787 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-24999037 | usd |
CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-29155787 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24999037 | usd |
CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.10 | |
CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.10 | |
CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.15 | |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.15 | |
CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
302607192 | shares |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
302607192 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
167144351 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
167144351 | shares |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
83112171 | usd |
CY2024Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
1242649 | usd |
CY2024Q1 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
2847500 | usd |
CY2024Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
-163516 | usd |
CY2024Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
3148308 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-29155787 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
18592188 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
-383923 | usd |
CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
3024389 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24999037 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
104820548 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-29155787 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24999037 | usd |
CY2024Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1960844 | usd |
CY2023Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
640362 | usd |
CY2024Q1 | wkhs |
Change In Fair Value Notes And Warrant
ChangeInFairValueNotesAndWarrant
|
-7205039 | usd |
CY2023Q1 | wkhs |
Change In Fair Value Notes And Warrant
ChangeInFairValueNotesAndWarrant
|
0 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-24750 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-232001 | usd |
CY2024Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3370204 | usd |
CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3024389 | usd |
CY2024Q1 | wkhs |
Change In Inventory And Prepaid Purchases Reserve
ChangeInInventoryAndPrepaidPurchasesReserve
|
-2074785 | usd |
CY2023Q1 | wkhs |
Change In Inventory And Prepaid Purchases Reserve
ChangeInInventoryAndPrepaidPurchasesReserve
|
-149496 | usd |
CY2024Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-2937925 | usd |
CY2023Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
0 | usd |
CY2024Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-111363 | usd |
CY2023Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-221262 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
|
-2702322 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
|
-120273 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
6470772 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
13320359 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
36216 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
749125 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
4540735 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
2536424 | usd |
CY2024Q1 | wkhs |
Increase Decrease In Extended Warranty Liability
IncreaseDecreaseInExtendedWarrantyLiability
|
-1303420 | usd |
CY2023Q1 | wkhs |
Increase Decrease In Extended Warranty Liability
IncreaseDecreaseInExtendedWarrantyLiability
|
-141086 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-17963578 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-32749402 | usd |
CY2024Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
3025775 | usd |
CY2023Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
5404727 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-3025775 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-5404727 | usd |
CY2024Q1 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
12125000 | usd |
CY2023Q1 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
0 | usd |
CY2024Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
4366649 | usd |
CY2023Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
18592188 | usd |
CY2024Q1 | us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
-206265 | usd |
CY2023Q1 | us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
-219861 | usd |
CY2024Q1 | wkhs |
Exercise Of Warrants And Options And Restricted Share Award Activity
ExerciseOfWarrantsAndOptionsAndRestrictedShareAwardActivity
|
-163516 | usd |
CY2023Q1 | wkhs |
Exercise Of Warrants And Options And Restricted Share Award Activity
ExerciseOfWarrantsAndOptionsAndRestrictedShareAwardActivity
|
-383923 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-8128132 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
17988404 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-29117485 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-20165725 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
35845915 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
99276301 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
6728430 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
79110576 | usd |
CY2024Q1 | wkhs |
Revenue From Contract With Customer Excluding Assessed Tax Net Of Returns And Allowances
RevenueFromContractWithCustomerExcludingAssessedTaxNetOfReturnsAndAllowances
|
1300000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-18000000 | usd |
CY2024Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
6700000 | usd |
CY2024Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1800000 | usd |
CY2024Q1 | us-gaap |
Inventory Net
InventoryNet
|
49900000 | usd |
CY2024Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
14200000 | usd |
CY2024Q1 | wkhs |
Working Capital
WorkingCapital
|
24200000 | usd |
CY2024Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-780700000 | usd |
CY2024Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2024Q1 | us-gaap |
Sale Leaseback Transaction Net Book Value
SaleLeasebackTransactionNetBookValue
|
34500000 | usd |
CY2024Q1 | us-gaap |
Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
|
0.20 | |
CY2024Q1 | wkhs |
Restructuring And Related Cost Executive Payment Deferral Percent
RestructuringAndRelatedCostExecutivePaymentDeferralPercent
|
0.20 | |
CY2024Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses and related disclosures in the accompanying notes.</span></div> | |
CY2024Q1 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
34067558 | usd |
CY2023Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
32682324 | usd |
CY2024Q1 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
3249984 | usd |
CY2023Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
2892329 | usd |
CY2024Q1 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
22603148 | usd |
CY2023Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
18309829 | usd |
CY2024Q1 | us-gaap |
Inventory Gross
InventoryGross
|
59920690 | usd |
CY2023Q4 | us-gaap |
Inventory Gross
InventoryGross
|
53884482 | usd |
CY2024Q1 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
10068312 | usd |
CY2023Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
8476290 | usd |
CY2024Q1 | us-gaap |
Inventory Net
InventoryNet
|
49852378 | usd |
CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
45408192 | usd |
CY2024Q1 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
10100000 | usd |
CY2023Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
8500000 | usd |
CY2024Q1 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
4700000 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
4700000 | usd |
CY2024Q1 | us-gaap |
Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
|
6813159 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
|
7908087 | usd |
CY2024Q1 | us-gaap |
Contract With Customer Asset Accumulated Allowance For Credit Loss Current
ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent
|
1841990 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Asset Accumulated Allowance For Credit Loss Current
ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent
|
1999068 | usd |
CY2024Q1 | us-gaap |
Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
|
4971169 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
|
5909019 | usd |
CY2024Q1 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
1341357 | usd |
CY2023Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
1283146 | usd |
CY2024Q1 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
981261 | usd |
CY2023Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
908997 | usd |
CY2024Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
7293787 | usd |
CY2023Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
8101162 | usd |
CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1339295 | usd |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1693415 | usd |
CY2024Q1 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
4700000 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
4700000 | usd |
CY2024Q1 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
0 | usd |
CY2023Q1 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
100000 | usd |
CY2024Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
3562467 | usd |
CY2023Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
2083808 | usd |
CY2024Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
3089575 | usd |
CY2023Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
2778932 | usd |
CY2024Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
6652042 | usd |
CY2023Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
4862740 | usd |
CY2023Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
1902647 | usd |
CY2022Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
2207674 | usd |
CY2024Q1 | us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
85194 | usd |
CY2023Q1 | us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
287813 | usd |
CY2024Q1 | us-gaap |
Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
|
-1218226 | usd |
CY2023Q1 | us-gaap |
Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
|
146727 | usd |
CY2024Q1 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
599227 | usd |
CY2023Q1 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
2066588 | usd |
CY2024Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2024Q1 | us-gaap |
Share Price
SharePrice
|
0.24 | |
CY2024Q1 | us-gaap |
Share Price
SharePrice
|
0.27 | |
CY2024Q1 | us-gaap |
Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
|
P5Y | |
CY2024Q1 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
79077 | usd |
CY2023Q1 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
58307 | usd |
CY2024Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
557604 | usd |
CY2023Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
572340 | usd |
CY2024Q1 | us-gaap |
Lease Cost
LeaseCost
|
636681 | usd |
CY2023Q1 | us-gaap |
Lease Cost
LeaseCost
|
630647 | usd |
CY2024Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
3942958 | usd |
CY2023Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
4174800 | usd |
CY2024Q1 | us-gaap |
Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
|
5570992 | usd |
CY2023Q4 | us-gaap |
Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
|
5621181 | usd |
CY2024Q1 | wkhs |
Lease Right Of Use Assets
LeaseRightOfUseAssets
|
9513950 | usd |
CY2023Q4 | wkhs |
Lease Right Of Use Assets
LeaseRightOfUseAssets
|
9795981 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
6061502 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
6292954 | usd |
CY2024Q1 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
2402699 | usd |
CY2023Q4 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
2548184 | usd |
CY2024Q1 | wkhs |
Lease Liability
LeaseLiability
|
8464201 | usd |
CY2023Q4 | wkhs |
Lease Liability
LeaseLiability
|
8841138 | usd |
CY2024Q1 | wkhs |
Lease Liability Current
LeaseLiabilityCurrent
|
3416636 | usd |
CY2023Q4 | wkhs |
Lease Liability Current
LeaseLiabilityCurrent
|
3560612 | usd |
CY2024Q1 | wkhs |
Lease Liability Noncurrent
LeaseLiabilityNoncurrent
|
5047565 | usd |
CY2023Q4 | wkhs |
Lease Liability Noncurrent
LeaseLiabilityNoncurrent
|
5280526 | usd |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
17500000 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
|
3100000 | shares |
CY2024Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3370205 | usd |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
292429 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
10.27 | |
CY2023 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P6Y8M12D | |
CY2024Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0 | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
292429 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
|
247023 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
|
10.27 | |
CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
|
P5Y4M24D | |
CY2022Q1 | wkhs |
Sale Of Stock Authorized Amount
SaleOfStockAuthorizedAmount
|
175000000 | usd |
CY2024Q1 | us-gaap |
Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
|
2700000 | usd |
CY2024Q1 | wkhs |
Sale Of Stock Remaining Authorized Amount
SaleOfStockRemainingAuthorizedAmount
|
95600000 | usd |
CY2024Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
75000000 | shares |
CY2024Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2024Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2024Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2024Q1 | wkhs |
Number Of Classes Of Stock
NumberOfClassesOfStock
|
1 | class_of_stock |
CY2024Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2024Q1 | wkhs |
Common Stock Number Of Votes On Each Share
CommonStockNumberOfVotesOnEachShare
|
1 | vote |
CY2024Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
450000000 | shares |
CY2024Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2024Q1 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
1000000 | usd |
CY2023Q1 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
1000000 | usd |
CY2024Q1 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
0 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
0 | usd |
CY2024Q1 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false | |
CY2024Q1 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2024Q1 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2024Q1 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false |